Trials / Sponsors / Aqualung Therapeutics Corp.
Aqualung Therapeutics Corp.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | 2023-12-01 |
| Completed | First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100 ARDS, Human | Phase 1 | 2022-07-05 |